The University of Queensland

A recombinant Kunjin virus replicon vaccine will protect against the growth of a tumour expressing a tumour specific antigen (1999–2000)

Grant type:

Queensland Cancer Fund

Researchers:

• 

  Emeritus Professor Robert Tindle

  Emeritus Professor
  

  School of Chemistry and Molecular Biosciences

  Faculty of Science

Funded by:

Queensland Cancer Fund